• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

CT HEALTHCARE TRUST PLC

Notes

No. Proposition For Against Abstain
1

THAT, WITHOUT PREJUDICE TO ANY SUBSISTING OR OTHER AUTHORITY CONFERRED ON THE COMPANY, THE COMPANY BE AND IS HEREBY GENERALLY AND UNCONDITIONALLY AUTHORISED FOR THE PURPOSES OF SECTION 701 OF THE COMPANIES ACT 2006 (THE ACT) TO MAKE MARKET PURCHASES (WITHIN THE MEANING OF SECTION 693(4) OF THE ACT) OF ORDINARY SHARES WITH A NOMINAL VALUE OF 0.01 EACH IN THE CAPITAL OF THE COMPANY (THE SHARES) ACQUIRED BY J.P. MORGAN CAZENOVE PURSUANT TO THE TENDER OFFER TO BE MADE BY IT ON THE TERMS AND SUBJECT TO THE CONDITIONS SET OUT IN THE CIRCULAR OF THE COMPANY DATED 7 AUGUST 2026 (THE CIRCULAR), PROVIDED THAT: (A) THE MAXIMUM NUMBER OF SHARES AUTHORISED TO BE PURCHASED SHALL BE 6,998,907 SHARES; (B) THE PRICE WHICH MAY BE PAID FOR A SHARE SHALL BE THE TENDER PRICE, AS DEFINED IN THE CIRCULAR; AND (C) THE AUTHORITY HEREBY CONFERRED SHALL EXPIRE ON 30 SEPTEMBER 2026 (UNLESS SUCH AUTHORITY IS RENEWED PRIOR TO SUCH DATE), SAVE THAT THE COMPANY MAY, PRIOR TO SUCH EXPIRY, ENTER INTO A CONTRACT TO PURCHASE SHARES WHICH WILL OR MAY BE COMPLETED OR EXECUTED WHOLLY OR PARTLY AFTER SUCH EXPIRY AND MAKE A PURCHASE OF SUCH SHARES PURSUANT TO ANY SUCH CONTRACT

2

THAT UP TO 6,998,907 SHARES VALIDLY TENDERED UNDER THE TENDER OFFER FOR PURCHASE BY J.P. MORGAN CAZENOVE MAY BE SOLD FOR CASH BY J.P. MORGAN CAZENOVE TO PERSONS WHO AGREE TO ACQUIRE SUCH SHARES AT A PRICE EQUAL TO THE TENDER PRICE (AS DEFINED IN THE CIRCULAR) WHICH PRICE SHALL BE AT A DISCOUNT TO THE COMPANYS MOST RECENTLY PUBLISHED NET ASSET VALUE PER SHARE ON THE DATE ON WHICH SUCH SALE IS EFFECTED